Brain Cancer

Medical illustrations by Erin Moore explaining novel treatments for glioblastoma.

An organization does not have to be huge to do great things. In fact, armed with a dedicated board and a spunky child, Thea's Star of Hope is helping make advancements in pediatric brain cancer.

Over the last 15 years, and with more goals in 2016, ABC2 (Accelerate Brain Cancer Cure) advances breakthroughs in brain cancer research. Learn more in a conversation with Max Wallace the ABC2 CEO.

New treatments, such as immunotherapy, are continuing to prove successful for patients with glioblastoma, one of the most dangerous cancers.

The coming years look promising for advances in treatment of pediatric brain cancer, according to Matthias A. Karajannis.

Ill or not, so many people suffer. But perhaps in sharing that suffering we can change the face of illness, health, suffering and everything in between.

Andrew S. Chi discusses some of the exciting new advancements for treatment of brain cancer.

Learn about inner strength, self-care and other helpful skills to feel better through the Reimagine Core Program.

To gain insight into the research needed in glioblastoma, we interviewed Robert M. Prins, an associate professor in residence at UCLA.

Kay Verble discusses a research endeavor to characterize long-term survivors of glioblastoma multiforme (GBM).

Greg Cantwell, a survivor of glioblastoma multiforme (GBM) and the founder of Greg's Mission, discusses the need to support and educate patients with GBM.

Sherry Fox accepts her award as one of our 2015 GBM Heroes.

Santosh Kesari discusses the need to think outside the box when conducting research in glioblastoma multiforme (GBM).

We often have to face things in illnesses that feel bigger than we think we can manage, yet somehow we balance the fear with the hope and find humanity in the process.

The responsibility of caregiving is increasingly being placed on family members.

Award-winning actress and author Valerie Harper pays tribute to CURE's inaugural class of GBM Heroes.

Immunotherapies continue to be studied and approved across multiple tumor types, among them, malignancies of the central nervous system.

CURE spoke with Gilbert at the 2015 Society for Neuro-Oncology Annual Meeting, a meeting of over 1,000 oncology professionals.

It was a night filled with inspiration, shared purpose and hope, as four heroes who have given selflessly in their efforts to improve the lives of people impacted by glioblastoma were honored at the 1st Annual Glioblastoma Multiforme (GBM) Heroes Awards.

The approval was based on findings from the phase 3 EF-14 trial.

No doubt, dealing with cancer can be overwhelming. Learn 24 tips to find levels of comfort during cancer and support healing in the process.

This reanalysis confirmed that there is no difference for a radiotherapy-first versus a chemotherapy-first strategy in this setting, but there is a major difference in long-term outcomes for molecular stratification independent of treatment.

These data were presented in late May at the 2015 annual meeting of the American Society of Clinical Oncology (ASCO), a gathering of nearly 30,000 oncology professionals in Chicago.

Patients with newly diagnosed glioblastoma are now being accepted at two institutions to enter a phase 2 study to assess the efficacy of the SurVaxM vaccine in combination with standard chemotherapy.

It's hard to honor our bodies and respect what we need, especially when we are sick bodies living in a sea of the well.

Could immediate access to care be the turning point?

Former U.S. president Jimmy Carter provided an update on his health today in a press conference, announcing that he has melanoma.

Low-grade gliomas may be classified into three distinct prognostic categories based on genomic data.

Heidi Gottlieb, a brain tumor survivor and the director and founder of Brain Matters, gives advice to other patients and survivors.